With a staggering $7.2 billion allocated to the National Cancer Institute last year, it's time to pull back the curtain on where the immense fight against cancer is being funded and if this financial firepower is truly hitting its mark.
Key Takeaways
- In fiscal year 2023, the National Cancer Institute (NCI) received a budget of $7.2 billion for cancer research, marking a 5.3% increase from FY2022
- The NCI allocated $1.1 billion to cancer biology research in FY2022, representing 16% of its total research budget
- From 2018 to 2022, NCI extramural grants for cancer research averaged $5.8 billion annually, supporting over 5,000 awards
- American Cancer Society (ACS) invested $150 million in research grants in 2022, funding 700+ projects worldwide
- Susan G. Komen Foundation granted $80 million for breast cancer research in 2023
- Stand Up To Cancer awarded $500 million since 2008 to collaborative cancer projects
- World Cancer Research Fund International granted £50 million ($65M) since 1981 for diet-cancer links
- European Union's Horizon Europe program allocated €1 billion ($1.1B) for cancer research 2021-2027
- Cancer Research UK total funding £2 billion over 10 years to 2023
- In 2022, NCI allocated $800 million to breast cancer research, 11% of total budget
- Prostate cancer received $350 million from NCI in FY2023, focusing on disparities
- Lung cancer NCI funding totaled $450 million in 2022, highest for any type due to incidence
- NCI cancer research funding grew 70% from $4.1 billion in 2010 to $7.0 billion in 2020
- Global cancer research investment rose from $50 billion in 2010 to $120 billion in 2022, CAGR 7%
- US private philanthropy for cancer increased 15% annually 2015-2023 to $5 billion yearly
Cancer research funding spans billions across federal programs, foundations, and global initiatives.
Funding Allocation by Cancer Type
1In 2022, NCI allocated $800 million to breast cancer research, 11% of total budget
Verified2Prostate cancer received $350 million from NCI in FY2023, focusing on disparities
Verified3Lung cancer NCI funding totaled $450 million in 2022, highest for any type due to incidence
Verified4Colorectal cancer got $300 million NCI allocation in FY2023 for screening tech
Directional5Pancreatic cancer NCI funding was $220 million in 2022, despite low survival
Single source6Leukemia/lymphoma NCI grants summed $400 million in FY2023
Verified7Brain cancer (CNS) received $250 million from NCI in 2022 for gliomas
Verified8Ovarian cancer NCI allocation $180 million FY2023, targeting PARP inhibitors
Verified9Liver cancer funding by NCI was $150 million in 2022, rising due to hep B/C links
Directional10Melanoma NCI grants $280 million in FY2023 for immunotherapy advances
Single source11Childhood cancers (all) NCI pediatric funding $250 million in 2022
Verified12Head and neck cancers NCI $120 million FY2023
Verified13Bladder cancer NCI allocation $100 million in 2022
Verified14Kidney (renal) cancer $140 million NCI 2023
Directional15Esophageal cancer NCI funding $80 million FY2022
Single source16Stomach (gastric) cancer $90 million NCI 2023
Verified17Thyroid cancer NCI grants $70 million 2022
Verified18Multiple myeloma NCI $110 million FY2023
Verified19Non-Hodgkin lymphoma $200 million NCI 2022
Directional20Cervical cancer NCI allocation $60 million 2023 HPV focus
Single source21Uterine/endometrial $75 million NCI FY2022
Verified22Testicular cancer $40 million NCI 2023
Verified23Soft tissue sarcoma $50 million NCI 2022
Verified24Mesothelioma $30 million NCI FY2023
DirectionalFunding Allocation by Cancer Type Interpretation
While funding reflects the brutal arithmetic of incidence and mortality, these numbers map a determined, if imperfect, battle plan against a cunning and varied enemy.
Historical Trends and Projections
1NCI cancer research funding grew 70% from $4.1 billion in 2010 to $7.0 billion in 2020
Verified2Global cancer research investment rose from $50 billion in 2010 to $120 billion in 2022, CAGR 7%
Verified3US private philanthropy for cancer increased 15% annually 2015-2023 to $5 billion yearly
Verified4NCI budget as % of NIH total declined from 20% in 2000 to 15% in 2023 despite absolute growth
Directional5DoD cancer research funding tripled from $50 million in 2000 to $150 million in 2022
Single source6Cancer immunotherapy funding exploded from $1B in 2015 to $20B in 2023 globally
Verified7CAR-T cell therapy R&D investment reached $10 billion cumulative by 2023 from 2017 start
Verified8NCI projections estimate $8.5 billion budget by FY2027 under current trends
Verified9Pharma oncology R&D spend projected to hit $150 billion by 2028 from $100B 2023
Directional10Pediatric cancer funding stagnant at $250M NCI level since 2015 adjusted for inflation
Single source11Global south cancer research funding grew 200% 2010-2022 to $2 billion annually
Verified12Precision oncology grants doubled from 1,000 in 2018 to 2,500 in 2023 NCI-wide
Verified13Cancer survival rates improved 30% since 1990 correlating with funding rise
Verified14EU cancer research funding projected €4 billion under Horizon 2028-2034
Directional15Venture capital in cancer biotech fell 40% in 2023 from 2021 peak of $25B
Single source16NCI extramural awards increased 20% from 4,500 in 2015 to 5,400 in 2023
Verified17Philanthropic funding for rare cancers up 50% since 2020 to $500M globally
Verified18Cancer Moonshot funding legacy: $2B total 2016-2023, projected $3B more
Verified19Inflation-adjusted NCI budget flat 2010-2020 before 5% annual rises post-2021
Directional20International collaborative trials funding tripled to 500 projects 2015-2023
Single source21mRNA cancer vaccine funding surged $5B since 2020 COVID tech transfer
VerifiedHistorical Trends and Projections Interpretation
While we've armed our global war on cancer with a truly staggering arsenal of capital—where even the DoD's efforts have tripled and immunotherapy enjoys a meteoric, twenty-fold boom—it remains a conflict fought with uneven ammunition, as seen in the stubborn stagnation of pediatric funding and the fact that the NCI's share of the NIH pie has actually shrunk, proving that even in a gold rush, some trenches are still under-resourced.
International Funding
1World Cancer Research Fund International granted £50 million ($65M) since 1981 for diet-cancer links
Verified2European Union's Horizon Europe program allocated €1 billion ($1.1B) for cancer research 2021-2027
Verified3Cancer Research UK total funding £2 billion over 10 years to 2023
Verified4Canadian Cancer Society invested CAD 1.2 billion ($900M USD) since 1938, CAD 50M yearly
Directional5INSERM France allocated €500 million ($550M) for cancer research in 2022 national plan
Single source6German Cancer Aid provided €400 million ($440M) since 1980, €40M in 2023
Verified7Japan Agency for Medical Research and Development (AMED) funded ¥100 billion ($700M) for cancer 2015-2023
Verified8Australian NHMRC granted AUD 300 million ($200M USD) for cancer research 2022-2023
Verified9Brazilian National Cancer Institute (INCA) budget R$1 billion ($200M USD) annually for research
Directional10Indian Council of Medical Research (ICMR) allocated INR 5,000 crore ($600M) for oncology 2021-2026
Single source11South African Medical Research Council funded ZAR 200 million ($12M USD) for cancer in 2023
Verified12China National Natural Science Foundation cancer grants totaled CNY 10 billion ($1.4B) in 2022
Verified13WHO's International Agency for Research on Cancer (IARC) budget $60 million in 2023 for global epidemiology
Verified14EU Mission on Cancer invested €400 million ($440M) for pediatric cancers 2022-2027
Directional15UK NIHR funded £200 million ($250M) for cancer trials in 2023
Single source16Israel's Ministry of Health cancer research budget NIS 500 million ($135M) in 2023
Verified17Russian Science Foundation granted RUB 5 billion ($55M) for oncology 2022
Verified18Mexico's CONACYT funded MXN 1 billion ($50M) for cancer genomics 2021-2024
Verified19Singapore NMRC allocated SGD 100 million ($75M) for precision oncology 2023
Directional20WHO Special Initiative for NCDs provided $100 million for low-middle income cancer research 2022
Single source21Global Cancer Observatory (GLOBOCAN) funded by IARC with $20 million annually for data
Verified22EU 4th Cancer Framework Programme invested €1.2 billion 2021-2027
VerifiedInternational Funding Interpretation
Despite the colossal global investment in cancer research, which resembles a frenzied international bake-off with everyone furiously mixing their own funding recipes, the sobering truth remains that we're still just scratching the surface of this complex disease.
Private Sector Funding
1American Cancer Society (ACS) invested $150 million in research grants in 2022, funding 700+ projects worldwide
Verified2Susan G. Komen Foundation granted $80 million for breast cancer research in 2023
Verified3Stand Up To Cancer awarded $500 million since 2008 to collaborative cancer projects
Verified4Leukemia & Lymphoma Society funded $1.3 billion historically, with $100 million in 2022 for blood cancers
Directional5Cancer Research UK provided £600 million ($750 million USD) annually for cancer research in 2023
Single source6Damon Runyon Cancer Research Foundation granted $50 million in 2022 to early-career scientists
Verified7Lustgarten Foundation allocated $30 million for pancreatic cancer since 2002, peaking at $10 million in 2023
Verified8V Foundation for Cancer Research awarded $350 million total by 2023, $40 million in 2022
Verified9Breast Cancer Research Foundation granted $75 million in 2023 for metastasis and subtypes
Directional10Alex's Lemonade Stand Foundation funded $250 million for pediatric cancer since 2005, $25 million in 2023
Single source11Congressionally Directed Medical Research Program private partnerships added $20 million matching funds in 2022
Verified12Gateway for Cancer Research provided $40 million for innovative projects since 2004
Verified13Melville Trust awarded $15 million for urologic cancer research in 2023
Verified14Hyundai Hope On Wheels granted $20 million for pediatric cancer in 2022
Directional15Swim Across America funded $10 million annually for cancer research grants in 2023
Single source16The Hope Foundation provided $50 million for global cancer research partnerships in 2022
Verified17Ludwig Cancer Research invested $1.5 billion since 1971, $100 million yearly average
Verified18Terry Fox Foundation granted CAD 800 million ($600M USD) for cancer research since 1988
Verified19Cancer Research Institute allocated $40 million for immunotherapy in 2023
Directional20Ovarian Cancer Research Alliance funded $100 million since 1997, $12 million in 2023
Single source21Mesothelioma Applied Research Foundation granted $20 million total by 2023
Verified22Rally Foundation awarded $10 million for pediatric cancer since 2006
Verified23Polaris Pharmaceuticals private funding for AML research hit $15 million in 2022
Verified24PhRMA member companies invested $12 billion in oncology R&D in 2022
Directional25Biotech firms received $5 billion VC funding for cancer therapies in 2023
Single sourcePrivate Sector Funding Interpretation
While these staggering figures reveal a powerful and well-funded army fighting cancer on multiple fronts, one can't help but feel we’re still funding the siege of a formidable castle with far too many secret passages and an infuriating habit of rebuilding its walls overnight.
US Federal Funding
1In fiscal year 2023, the National Cancer Institute (NCI) received a budget of $7.2 billion for cancer research, marking a 5.3% increase from FY2022
Verified2The NCI allocated $1.1 billion to cancer biology research in FY2022, representing 16% of its total research budget
Verified3From 2018 to 2022, NCI extramural grants for cancer research averaged $5.8 billion annually, supporting over 5,000 awards
Verified4In 2021, the NCI's Cancer Moonshot initiative received $1.8 billion in additional funding over 7 years, focusing on immunotherapy and early detection
Directional5NCI intramural research funding reached $570 million in FY2023, funding 1,200 scientists across 60 labs
Single source6The Department of Defense (DoD) Congressionally Directed Medical Research Program allocated $142 million to breast cancer research in FY2022
Verified7DoD prostate cancer research funding totaled $100 million in FY2023 under the Peer Reviewed Cancer Research Program
Verified8VA's National Oncology Research Program provided $50 million for cancer research in 2022, targeting veteran-specific cancers
Verified9In 2020, ARPA-H announced $500 million for cancer innovation through the Cancer Moonshot
Directional10NCI's SBIR/STTR program awarded $150 million to small businesses for cancer tech in FY2022
Single source11CDC's National Comprehensive Cancer Control Program funded $60 million across 50 states in 2023 for prevention research
Verified12FDA's Oncology Center of Excellence received $40 million in FY2023 for regulatory science in cancer drugs
Verified13NIH's total cancer research funding outside NCI was $300 million in 2022 from other institutes like NIAID
Verified14In FY2021, NCI training grants supported 4,500 fellows with $250 million for cancer research careers
Directional15BRAIN Initiative allocated $20 million to neuro-oncology research in 2023 as part of NCI collaboration
Single source16Precision Medicine Initiative (All of Us) provided $100 million for cancer genomics in 2022
Verified17NCI's Community Oncology Research Program (NCORP) received $100 million in FY2023 for community-based trials
Verified18DoD ovarian cancer research funding was $25 million in FY2022
Verified19NCI's Applied Research Program funded $80 million for health services research in cancer in 2021
Directional20In 2023, NCI surveillance funding through SEER program was $120 million, covering 48% population coverage
Single source21HRSA's cancer programs in rural areas received $30 million in 2022 for research access
Verified22NCI's Cancer Centers Program supported 72 centers with $450 million in FY2023
Verified23DoD lung cancer research got $40 million in FY2023
Verified24NCI's Pediatric Oncology Program funded $150 million in 2022 for childhood cancers
Directional25In FY2022, NCI epidemiology research allocation was $350 million
Single source26BARDA invested $200 million in cancer vaccine development in 2023
Verified27NCI's Rare Cancer Research Program provided $50 million for 200+ rare types in 2021
Verified28DoD pancreatic cancer funding reached $30 million in FY2022
Verified29NCI's Behavioral Research Program got $120 million in FY2023 for lifestyle interventions
Directional30In 2022, NCI clinical trials support totaled $800 million across 1,000+ trials
Single sourceUS Federal Funding Interpretation
The sheer magnitude of cancer funding, from billions for moonshots to millions for a single rare type, paints a picture of a nation marshalling every conceivable financial weapon against an enemy that demands no less than a full-scale economic siege.
Sources & References
- Reference 1CANCERcancer.govVisit source
- Reference 2REPORTERreporter.nih.govVisit source
- Reference 3CDMRPcdmrp.health.milVisit source
- Reference 4RESEARCHresearch.va.govVisit source
- Reference 5ARPA-Harpa-h.govVisit source
- Reference 6SBIRsbir.cancer.govVisit source
- Reference 7CDCcdc.govVisit source
- Reference 8FDAfda.govVisit source
- Reference 9REPORTreport.nih.govVisit source
- Reference 10BRAININITIATIVEbraininitiative.nih.govVisit source
- Reference 11ALLOFUSallofus.nih.govVisit source
- Reference 12NCORPncorp.cancer.govVisit source
- Reference 13CANCERCONTROLcancercontrol.cancer.govVisit source
- Reference 14SEERseer.cancer.govVisit source
- Reference 15HRSAhrsa.govVisit source
- Reference 16CANCERCENTERScancercenters.cancer.govVisit source
- Reference 17EPIepi.grants.cancer.govVisit source
- Reference 18MEDICALCOUNTERMEASURESmedicalcountermeasures.govVisit source
- Reference 19CANCERcancer.orgVisit source
- Reference 20KOMENkomen.orgVisit source
- Reference 21STANDUPTOCANCERstanduptocancer.orgVisit source
- Reference 22LLSlls.orgVisit source
- Reference 23CANCERRESEARCHUKcancerresearchuk.orgVisit source
- Reference 24DAMONRUNYONdamonrunyon.orgVisit source
- Reference 25LUSTGARTENlustgarten.orgVisit source
- Reference 26Vv.orgVisit source
- Reference 27BCRFbcrf.orgVisit source
- Reference 28ALEXSLEMONADEalexslemonade.orgVisit source
- Reference 29GATEWAYCRgatewaycr.orgVisit source
- Reference 30MELVILLETRUSTmelvilletrust.orgVisit source
- Reference 31HYUNDAINEWShyundainews.comVisit source
- Reference 32SWIMACROSSAMERICAswimacrossamerica.orgVisit source
- Reference 33THEHOPEFOUNDATIONthehopefoundation.orgVisit source
- Reference 34LUDWIGCANCERRESEARCHludwigcancerresearch.orgVisit source
- Reference 35TERRYFOXterryfox.orgVisit source
- Reference 36CANCERRESEARCHcancerresearch.orgVisit source
- Reference 37OCRAHOPEocrahope.orgVisit source
- Reference 38CUREMESOcuremeso.orgVisit source
- Reference 39RALLYFOUNDATIONrallyfoundation.orgVisit source
- Reference 40POLARISPHARMApolarispharma.comVisit source
- Reference 41PHRMAphrma.orgVisit source
- Reference 42BIOSPACEbiospace.comVisit source
- Reference 43WCRFwcrf.orgVisit source
- Reference 44ECec.europa.euVisit source
- Reference 45CANCERcancer.caVisit source
- Reference 46INSERMinserm.frVisit source
- Reference 47DEUTSCHLANDKREBSSTIFTUNGdeutschlandkrebsstiftung.deVisit source
- Reference 48AMEDamed.go.jpVisit source
- Reference 49NHMRCnhmrc.gov.auVisit source
- Reference 50INCAinca.gov.brVisit source
- Reference 51ICMRicmr.gov.inVisit source
- Reference 52SAMRCsamrc.ac.zaVisit source
- Reference 53NSFCnsfc.gov.cnVisit source
- Reference 54IARCiarc.who.intVisit source
- Reference 55RESEARCH-AND-INNOVATIONresearch-and-innovation.ec.europa.euVisit source
- Reference 56NIHRnihr.ac.ukVisit source
- Reference 57HEALTHhealth.gov.ilVisit source
- Reference 58RSCFrscf.ruVisit source
- Reference 59CONAHCYTconahcyt.mxVisit source
- Reference 60NMRCnmrc.gov.sgVisit source
- Reference 61WHOwho.intVisit source
- Reference 62GCOgco.iarc.frVisit source
- Reference 63CANCER-EUROPEcancer-europe.euVisit source
- Reference 64NATUREnature.comVisit source
- Reference 65MCKINSEYmckinsey.comVisit source
- Reference 66CBOcbo.govVisit source
- Reference 67IQVIAiqvia.comVisit source
- Reference 68STJUDEstjude.orgVisit source
- Reference 69UICCuicc.orgVisit source
- Reference 70OCGocg.cancer.govVisit source
- Reference 71RARECANCERSrarecancers.org.auVisit source
- Reference 72KFFkff.orgVisit source
- Reference 73CLINICALTRIALSclinicaltrials.govVisit source
- Reference 74MODERNATXmodernatx.comVisit source